glp-1 drugs sleep apnea Survey: Providers Want GLP-1s Approved for FDA approves Eli Lilly's weight

10.1038/s41433-021-01741-5 91

Muscle mass loss deserves specific attention

News articles abound about the fears around high prices for GLP-1s, and Senators are claiming the prices are unjustifiably high because of how many patients could benefit from them if they were cheaper

It should be noted that these unimolecular compounds have been tested only in preclinical models and have not been compared with other dual receptor agonists such as tirzepatide

The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome

The considerable cardiovascular benefits associated with specific GLP-1 agonists and the well-documented efficacy of GLP-1 agonists in diabetes care are two key drivers driving this industry ahead